These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1007365)

  • 1. [The blood picture in progressive scleroderma].
    Schramm P; Brachtel R
    Z Hautkr; 1976 Dec; 51(24):1025-8. PubMed ID: 1007365
    [No Abstract]   [Full Text] [Related]  

  • 2. [Decreased blood fluidity in progressive systemic scleroderma].
    Ernst E; Lohmaier EF; Meurer M; Gerstmeier J
    Z Rheumatol; 1990; 49(3):155-9. PubMed ID: 2378174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The blood coagulation system in progressive systemic scleroderma].
    Sica S; Paoletti S; Storti S; Pagano L; Marra R; Garcovich A
    Minerva Med; 1987 Dec; 78(24):1831-4. PubMed ID: 2448705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the oxyhemoglobin dissociation curve in various pathological forms].
    Pacia A
    Arch Monaldi; 1984; 39(1-2):45-52. PubMed ID: 6442556
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelets in renal scleroderma.
    Amenta PS; Katz SM
    Arch Pathol Lab Med; 1983 Aug; 107(8):439-40. PubMed ID: 6688172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential blood pictures in progressive and circumscribed scleroderma].
    Roder H; Pinzer B
    Dermatol Monatsschr; 1972 Jun; 158(6):417-20. PubMed ID: 5044634
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemostasis in patients with circumscribed and systemic scleroderma].
    Dovzhanskiĭ SI; Gerasimova MV
    Vestn Dermatol Venerol; 1988; (1):41-3. PubMed ID: 3364021
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemostasis in systemic scleroderma].
    Grebenev AL; Iakunin GA; Smolianitskiĭ AIa; Napalkova NN; Lavrova LA
    Klin Med (Mosk); 1981 Aug; 59(8):55-60. PubMed ID: 7289527
    [No Abstract]   [Full Text] [Related]  

  • 9. [The acute phase reaction in progressive systemic sclerosis].
    Lukác J; Hajzoková M; Ondrasík M; Zitnan D; Hrebík I
    Cas Lek Cesk; 1988 Jan; 127(3):80-3. PubMed ID: 2450651
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rheological and coagulative blood properties in patients with systemic scleroderma undergoing hyperbaric oxygenation in combined treatment].
    Iakunin GA; Grebenev AL; Lukich VL; Smolianitskiĭ AIa; Grabskiĭ MA
    Ter Arkh; 1983; 55(7):120-4. PubMed ID: 6623377
    [No Abstract]   [Full Text] [Related]  

  • 11. [Content of free 17-oxycorticosteroids in the blood of patients with scleroderma].
    Shcherbakova IB
    Vestn Dermatol Venerol; 1967 Nov; 41(11):48-52. PubMed ID: 4313634
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood concentrations of pantothenic acid in patients with rheumatoid arthritis and scleroderma].
    Ambanelli U; Rosati R
    Rev Esp Reum Enferm Osteoartic; 1971; 14(1):26-33. PubMed ID: 5564541
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some data on the cytochemistry of peripheral blood neutrophils in scleroderma].
    Shapiro AM; Guseva NG; Komissarova IA
    Sov Med; 1971 May; 34(5):36-9. PubMed ID: 5159384
    [No Abstract]   [Full Text] [Related]  

  • 14. Endothelin-1 and cold provocation in health, primary Raynaud's phenomenon, and progressive systemic sclerosis.
    Dörffler-Melly J; Lüscher TF; Wenk M; Wen S; Bollinger A; Franzeck UK
    Microvasc Res; 1996 Sep; 52(2):193-7. PubMed ID: 8901448
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative creatine-creatinine studies in the scope of oral creatine loading in dermatomyositis and progressive scleroderma].
    Kreysel HW
    Hautarzt; 1966 Sep; 17(9):399-406. PubMed ID: 5997316
    [No Abstract]   [Full Text] [Related]  

  • 16. [The content of free amino acids and protein fractions in the blood serum of patients with systemic scleroderma].
    Zhuk RD; Khrupina AIa
    Vopr Revm; 1966; 6(3):40-2. PubMed ID: 5993388
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical value of soluble adhesion molecules in systemic scleroderma].
    Alekperov RT; Timchenko AV; Aleksandrova EN; Samsonov MIu; Guseva NG; Nasonova EL
    Klin Med (Mosk); 2003; 81(10):43-7. PubMed ID: 14664174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycosaminoglycans in progressive scleroderma].
    Herrmann K; Schinagl A; Gchinagl G; Haustein UF; Lohrisch I
    Dermatol Monatsschr; 1982 Nov; 168(11):761-5. PubMed ID: 7160507
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of some inflammatory, coagulative and immune parameters in progressive systemic sclerosis.
    Marra R; Pagano L; Storti S; Paoletti S; Garcovich A; Bizzi B
    Acta Med Pol; 1988; 29(1-2):81-8. PubMed ID: 3151425
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gas chromatographic study of the fatty acids in the blood of dermatological patients. I. Scleroderma; acne; contact eczema].
    Mariotti A; Guarnieri A
    Arch Ital Dermatol Venereol Sessuol; 1966; 34(4):258-82. PubMed ID: 4230881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.